61 – 70 of 78
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Experience with a new percutaneous port system, Percuseal(R), for intravenous injection in patients with haemophilia, von Willebrand disease and severe alpha1-antitrypsin deficiency.
(
- Contribution to journal › Article
-
Mark
Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.
(
- Contribution to journal › Article
- 2002
-
Mark
Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ).
(
- Contribution to journal › Article
-
Mark
Nutritional status and muscle strength in patients with emphysema and severe alpha(1)-antitrypsin deficiency.
(
- Contribution to journal › Article
- 1999
-
Mark
Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ)
(
- Contribution to journal › Article
- 1998
-
Mark
Adolescents with alpha1-antitrypsin deficiency have high alpha2-macroglobulin and low neutrophil lipocalin and elastase levels in plasma
(
- Contribution to journal › Article
-
Mark
Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ)
(
- Contribution to journal › Article
-
Mark
Effect of environmental and clinical factors on lung function and respiratory symptoms in adolescents with alpha1-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Lung function in alpha1-antitrypsin deficiency
1998)(
- Thesis › Doctoral thesis (compilation)
- 1997
-
Mark
Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ)
(
- Contribution to journal › Article